This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Contents — quick navigation | ||
|---|---|---|
| A | Basic information | ICD-10: G41.8 | Special Copayment Reduction: V125 | Coverage period: 5 years |
| B | Synonyms | Other types of SE; includes tonic SE, myoclonic SE, subtle SE, electrographic-only SE, etc. |
| C | Adult onset | Myoclonic SE: common in patients with severe brain injury (after cardiac arrest). Tonic SE: may occur in adult patients with LGS |
| S1 | History | Changing recognition of atypical types in the history of SE classification |
| S2 | Causes | Varies by SE type; brain injury, LGS, metabolic abnormalities, severe hypoxic encephalopathy |
| S3 | Genetics | Myoclonic SE: SCN1A, POLG; tonic SE: LGS-related genes |
| S4 | General epidemiology | Other types of SE are about 5–15% of all SE; a considerable proportion in intensive care units |
| S5 | Pathophysiology | Type-specific pathophysiology; common failure of seizure termination mechanisms |
| S6 | Symptoms | Clinical features by type: sustained tonic posturing, continuous myoclonus, loss of consciousness with subtle convulsions |
| S7 | Signs | EEG and clinical signs by type; key role of cEEG monitoring |
| S8 | Screening | cEEG monitoring in the intensive care unit; screening for the underlying disease |
| S9 | Diagnosis | Diagnosis by type classification; application of ILAE 2015 criteria |
| S10 | Treatment | Treatment by type; therapeutic limitations in myoclonic SE (posthypoxic) |
| S11 | Prognosis | Varies by type; posthypoxic myoclonic SE is extremely poor |
| S12 | Prevention | Brain-protective treatment after cardiac arrest; optimal management of LGS; intensive monitoring |
| S13 | References | 10 key references |
In the history of status epilepticus (SE) classification, systematic recognition of "other" types besides tonic-clonic SE and absence SE came relatively late. Interest in the diversity of SE grew from the 1960s, but atypical types were dealt with mainly at the level of case reports.
Tonic SE was observed mainly in patients with LGS and became known as "tonic SE in LGS." In 1966, Gastaut and colleagues described a continuous state of repetitive tonic seizures occurring during sleep. Myoclonic SE appears in various contexts, and in particular the fact that myoclonic SE occurring in hypoxic encephalopathy after cardiac arrest (distinguished from Lance-Adams syndrome) is associated with a poor prognosis was recognized in the 1970s–80s.
Subtle SE drew attention when Treiman et al. (1984) described a state in which convulsive SE fails to respond to treatment and the clinical manifestations of convulsions gradually diminish while seizures persist on EEG. Later, with the introduction of continuous EEG (cEEG) monitoring in ICU patients, various types of SE that had not been clinically recognized began to be discovered. The 2015 ILAE SE classification systematically organized these various types, integrating classification by the presence or absence of motor symptoms with classification by EEG pattern.
Recently, EEG-based concepts such as "electrographic SE only" and "prolonged epileptiform discharges" have become clinically important, and standardization of cEEG monitoring in the ICU setting is underway.
Other SE (G41.8) encompasses several clinical types, and the main causes differ by type.
The main genetic causes related to other SE types are as follows.
Genes associated with LGS (TSC1/2, CDKL5, ARX, etc.) form the genetic background of tonic SE. Genetic testing is used to identify the cause of the underlying LGS or developmental epileptic encephalopathy.
Rasmussen encephalitis is not a hereditary disease; it arises by an autoimmune mechanism (GluA3 receptor antibodies, mediated by cytotoxic T lymphocytes). Epilepsia partialis continua is characteristic.
Epidemiological data combining the other SE types are limited, but the proportion of all SE patients accounted for by these types is estimated at about 5–15%.
The lifetime incidence of tonic SE in patients with LGS is quite high (estimated at 20–40%). In particular, it often occurs during sleep and is sometimes not clinically recognized.
The incidence of myoclonic SE in patients with hypoxic encephalopathy after cardiac arrest is about 10–40%. When cEEG monitoring is performed in ICU patients, the proportion of electrographic seizures that are not clinically recognized reaches 8–34%.
Epilepsia partialis continua (EPC) is estimated to be a rare condition occurring in fewer than 1 per 100,000 people. Rasmussen encephalitis, malformations of cortical development, stroke, and others are the main causes.
In LGS, tonic SE is associated with the continuous occurrence of generalized paroxysmal fast activity (GPFA, ≥10 Hz) during sleep. A hyperexcitable state of brainstem-cortical pathways continuously activates the motor output that produces tonic posturing. The paradoxical effect of benzodiazepines (worsening of tonic seizures) observed in some LGS patients suggests the complexity of this mechanism.
Widespread cortical injury after cardiac arrest induces synchronized myoclonic discharges in cortical and subcortical structures. Cortical disinhibition is the key mechanism of myoclonic SE, caused by the loss of GABAergic inhibition. Distinguishing cortical myoclonus from myoclonus of subcortical origin is important for determining prognosis.
In prolonged convulsive SE, progressive internalization of GABA-A receptors reduces clinical convulsions while EEG seizure discharges persist. In this state, the brain is exposed to ongoing excitotoxic injury, which affects neurological outcome.
An excitation-inhibition imbalance around focal cortical lesions causes persistent focal seizure discharges. In Rasmussen encephalitis, cortical cell loss caused by cytotoxic T lymphocytes leads to progressively increasing excitability.
| SE type | Clinical features | Level of consciousness |
|---|---|---|
| Tonic SE | Continuous or repetitive generalized stiffening; limb extension; apnea possible; frequent during sleep | Lost or severely clouded |
| Myoclonic SE (posthypoxic) | Continuous myoclonus of the face and limbs; occurs after cardiac arrest; unconscious | Coma |
| Myoclonic SE (other) | Repetitive myoclonus of the limbs and trunk; rhythmic or irregular | Variable |
| Subtle SE | Subtle eye deviation, eyelid twitching, subtle twitching of fingers/toes; occurs after convulsive SE | Coma or severe clouding |
| Epilepsia partialis continua | Continuous focal clonic jerking of part of the body (hours to days); consciousness may be preserved | Generally preserved |
| Electrographic-only SE | No clinical signs; confirmed only by EEG | Coma (ICU patients) |
In other SE types, diagnosis based on clinical signs alone is often impossible or very difficult. In the intensive care unit, cEEG monitoring is essential for detecting subtle SE, electrographic-only SE, burst-suppression patterns, and so on. The American Clinical Neurophysiology Society (ACNS) recommends cEEG monitoring in specific patient groups in the intensive care unit (coma, intracerebral hemorrhage, history of epilepsy, post–cardiac arrest, etc.).
In posthypoxic myoclonic SE, asynchronous or synchronous myoclonus of the face (eyelids, perioral region) and limbs is observed. In epilepsia partialis continua, continuous rhythmic jerking is observed in part of the body (thumb, one side of the face, etc.), and consciousness is preserved.
According to ACNS guidelines, cEEG monitoring is recommended in the following patient groups.
Depending on the provoking cause, blood tests (lactate, amino acids, organic acids), electromyography (to distinguish cortical from subcortical myoclonus), and neuroimaging (brain MRI, especially DWI) are needed. When POLG-related myoclonic SE is suspected, genetic testing and liver function tests are performed.
Diagnosis of other SE is made by integrating motor type, level of consciousness, and EEG findings according to the ILAE 2015 SE classification criteria.
| Type | Diagnostic criteria |
|---|---|
| Tonic SE | Continuous/repetitive tonic seizures ≥5 minutes; generalized GPFA on EEG; underlying history of LGS |
| Myoclonic SE | Continuous myoclonic discharges; EEG correlate of cortical origin; causal context (hypoxia, LGS, JME, etc.) |
| Epilepsia partialis continua | Focal clonic jerking ≥1 hour; consciousness preserved; focal cortical EEG discharges |
| Subtle SE | Minimal clinical convulsions after convulsive SE; persistent seizures on EEG; no recovery of consciousness |
| Electrographic-only SE | No clinical symptoms; seizure discharges confirmed only by cEEG; ICU patients |
Among nonconvulsive SE types, the Salzburg criteria are useful for diagnosing electrographic-only SE. However, the clinical significance of seizure discharges within a burst-suppression pattern and the need to treat them are still debated.
In electrographic-only SE, the aggressiveness of treatment is decided according to the clinical context. Aggressive antiseizure treatment is recommended in patients with potential for recovery from brain injury, but treatment decisions in patients with irreversible severe brain injury involve ethical judgment.
| SE type | Prognosis |
|---|---|
| Tonic SE (LGS) | Follows the underlying prognosis of LGS; short-term mortality from SE itself is low, but repeated episodes cause functional decline |
| Posthypoxic myoclonic SE | Extremely poor; most die or remain in a vegetative state; some survive with Lance-Adams syndrome |
| Epilepsia partialis continua | Varies by underlying disease; Rasmussen encephalitis worsens progressively; other causes relatively favorable |
| Subtle SE | Poor; dependent on the severity of underlying brain injury; good outcome in fewer than 30% |
| Electrographic-only SE | Independent effect unclear; associated with the prognosis of the underlying disease |
In posthypoxic myoclonic SE, a burst-suppression pattern on EEG is an indicator of extremely poor prognosis and is used together with other indicators (somatosensory evoked potentials, NSE, neuroimaging) in neurological prognostication.